Infliximab Therapy Impacts the Peripheral Immune System of Immunomodulator and Corticosteroid Naive Patients with Crohn' Disease

Plasma transforming growth factor-ß1 level in inflammatory bowel disease

(2016) Z. Mesut Yalin KILIC et al.   Turkish Journal of Gastroenterology

Basal lymphoid aggregates in ulcerative colitis colon: a site for regulatory T cell action

(2010) B. Sitohy et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Emerging Biologics in the Treatment of Inflammatory Bowel Disease: What is Around the Corner?

(2010) Gionata Fiorino et al.   CURRENT DRUG TARGETS

The expression profile of functional regulatory T cells, CD4+CD25high+/forkhead box protein P3+, in patients with ulcerative colitis during active and quiescent disease

(2009) K. Kamikozuru et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis

(2009) Peter C. Taylor et al.   Nature Reviews Rheumatology

Diminution of Circulating CD4+CD25high T Cells in Naïve Crohn’s Disease

(2008) Patrick Chamouard et al.   DIGESTIVE DISEASES AND SCIENCES

Smad7 Controls Resistance of Colitogenic T Cells to Regulatory T Cell-Mediated Suppression

(2008) Massimo C. Fantini et al.   GASTROENTEROLOGY

Modulation of the Th1/Th2 Balance by Infliximab Improves Hyperthyroidism Associated with a Flare-up of Ulcerative Colitis

(2008) Kayoko Matsumura et al.   INFLAMMATORY BOWEL DISEASES

IL-21 and TGF-β are required for differentiation of human TH17 cells

(2008) Li Yang et al.   NATURE

The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt

(2008) Nicolas Manel et al.   NATURE IMMUNOLOGY

Tumor necrosis factor antagonist mechanisms of action: A comprehensive review

(2007) Daniel Tracey et al.   PHARMACOLOGY & THERAPEUTICS